Berg, Daniela

MDS clinical diagnostic criteria for Parkinson’s disease

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 7,653

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine

Lysosomal Storage Disorders ResearchParkinson's Disease Mechanisms and Treatments

Cited by 2,135

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsNeurology and Historical Studies

Cited by 859

Brain-first versus body-first Parkinson’s disease: a multimodal imaging case-control study

Horsager, J., Andersen, K. B., Knudsen, K., Skjærbæk, C., Fedorova, T. D., Okkels, N., Schaeffer, E., Bonkat, S. K., Geday, J., Otto, M., et al. (2020) · Brain

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 782

Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease

Robak, L. A., Jansen, I. E., van Rooij, J., Uitterlinden, A. G., Kraaij, R., Jankovic, J., Heutink, P., Shulman, J. M., International Parkinson’s Disease Genomics Consortium (IPDGC), Nalls, M. A., et al. (2017) · Brain

Lysosomal Storage Disorders ResearchParkinson's Disease Mechanisms and Treatments

Cited by 433

Prodromal Parkinson disease subtypes — key to understanding heterogeneity

Berg, D., Borghammer, P., Fereshtehnejad, S.-M., Heinzel, S., Horsager, J., Schaeffer, E., & Postuma, R. B. (2021) · Nature Reviews Neurology

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 409

Brain iron pathways and their relevance to Parkinson's disease

Berg, D., Gerlach, M., Youdim, M. B. H., Double, K. L., Zecca, L., Riederer, P., & Becker, G. (2001) · Journal of Neurochemistry

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 362

Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies

Bras, J., Guerreiro, R., Darwent, L., Parkkinen, L., Ansorge, O., Escott-Price, V., Hernandez, D. G., Nalls, M. A., Clark, L. N., Honig, L. S., et al. (2014) · Human Molecular Genetics

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 230

In vivo detection of iron and Neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage

Zecca, L., Berg, D., Arzberger, T., Ruprecht, P., Rausch, W. D., Musicco, M., Tampellini, D., Riederer, P., Gerlach, M., & Becker, G. (2005) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 214

S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway

Sathe, K., Maetzler, W., Lang, J. D., Mounsey, R. B., Fleckenstein, C., Martin, H. L., Schulte, C., Mustafa, S., Synofzik, M., Vukovic, Z., et al. (2012) · Brain

Parkinson's Disease Mechanisms and TreatmentsS100 Proteins and Annexins

Cited by 202

Loss of nocturnal blood pressure fall in various extrapyramidal syndromes

Schmidt, C., Berg, D., Herting, Prieur, S., Junghanns, S., Schweitzer, K., Globas, C., Schöls, L., Reichmann, H., & Ziemssen, T. (2009) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsCardiovascular Syncope and Autonomic Disorders

Cited by 113

Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease

Hochstrasser, H., Bauer, P., Walter, U., Behnke, S., Spiegel, J., Csoti, I., Zeiler, B., Bornemann, A., Pahnke, J., Becker, G., et al. (2004) · Neurology

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 111

Foundations of circadian medicine

Kramer, A., Lange, T., Spies, C., Finger, A.-M., Berg, D., & Oster, H. (2022) · PLOS Biology

Circadian rhythm and melatoninSleep and Work-Related Fatigue

Cited by 99

Retracted: Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease

Heinzel, S., Aho, V. T. E., Suenkel, U., von Thaler, A., Schulte, C., Deuschle, C., Paulin, L., Hantunen, S., Brockmann, K., Eschweiler, G. W., et al. (2020) · Annals of Neurology

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 95

Cellular FLICE-inhibitory Protein (cFLIP) Isoforms Block CD95- and TRAIL Death Receptor-induced Gene Induction Irrespective of Processing of Caspase-8 or cFLIP in the Death-inducing Signaling Complex

Kavuri, S. M., Geserick, P., Berg, D., Dimitrova, D. P., Feoktistova, M., Siegmund, D., Gollnick, H., Neumann, M., Wajant, H., & Leverkus, M. (2011) · Journal of Biological Chemistry

Cell death mechanisms and regulationNF-κB Signaling Pathways

Cited by 92

Genome-wide association study in essential tremor identifies three new loci

Müller, S. H., Girard, S. L., Hopfner, F., Merner, N. D., Bourassa, C. V., Lorenz, D., Clark, L. N., Tittmann, L., Soto-Ortolaza, A. I., Klebe, S., et al. (2016) · Brain

Deep Brain Stimulation and Movement DisordersGenetic Associations and Epidemiology

Cited by 88

Functional relevance of ceruloplasmin mutations in Parkinson's Disease

Hochstrasser, H., Tomiuk, J., Walter, U., Behnke, S., Spiegel, J., Krüger, R., Becker, G., Riess, O., & Berg, D. (2005) · The FASEB Journal

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 87

The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein—implications for Parkinson's disease.

Marx, F. P., Soehn, A. S., Berg, D., Melle, C., Schiesling, C., Lang, M., Kautzmann, S., Strauss, K. M., Franck, T., Engelender, S., et al. (2007) · The FASEB Journal

Parkinson's Disease Mechanisms and TreatmentsUbiquitin and proteasome pathways

Cited by 52

Atypical parkinsonism in C9orf72 expansions: a case report and systematic review of 45 cases from the literature

Wilke, C., Pomper, J. K., Biskup, S., Puskás, C., Berg, D., & Synofzik, M. (2016) · Journal of Neurology

Amyotrophic Lateral Sclerosis ResearchParkinson's Disease Mechanisms and Treatments

Cited by 43

Continuous leg dyskinesia assessment in Parkinson's disease –clinical validity and ecological effect

Ramsperger, R., Meckler, S., Heger, T., van Uem, J., Hucker, S., Braatz, U., Graessner, H., Berg, D., Manoli, Y., Serrano, J. A., et al. (2016) · Parkinsonism & Related Disorders

Parkinson's Disease Mechanisms and TreatmentsBalance, Gait, and Falls Prevention

Cited by 41

Pesticides and the Microbiome-Gut-Brain Axis: Convergent Pathways in the Pathogenesis of Parkinson’s Disease

Kulcsarova, K., Bang, C., Berg, D., & Schaeffer, E. (2023) · Journal of Parkinson’s Disease

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 40

Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals

Heinzel, S., Jureczek, J., Kainulainen, V., Nieminen, A. I., Suenkel, U., von Thaler, A.-K., Kaleta, C., Eschweiler, G. W., Brockmann, K., Aho, V. T. E., et al. (2024) · Scientific Reports

Gut microbiota and healthInflammatory Bowel Disease

Cited by 36

Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies

Gröger, A., & Berg, D. (2012) · Journal of Neural Transmission

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 34

High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia

Vijayaraghavan, S., Maetzler, W., Reimold, M., Lithner, C. U., Liepelt‐Scarfone, I., Berg, D., & Darreh‐Shori, T. (2014) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsParkinson's Disease Mechanisms and Treatments

Cited by 24